Evren Progresses to Semifinals of BioPitch at the 23rd Annual BioFlorida Conference
BioFlorida conducts an annual pitch competition among companies that are developing products in life sciences or health care, including biotechnology, pharmaceuticals, medical devices, diagnostics, health care IT, health care services and plant/animal sciences. The competition provides a platform for some of Florida’s most innovative companies and the opportunity to pitch to life science investors.
"This is Evren's second year being selected to pitch in the SemiFinals, and we are excited to show the panel what we have accomplished in the last year as we now look to raise $5M in our first institutional round," says Blythe Karow, President & CEO of Evren Technologies.
The contest accepted an initial 50 entrants and 12 companies, including Evren, were selected for the next round of presentations Oct. 26-28. As a feature event of the BioFlorida Conference, the final three most promising startups companies will present Oct. 29 and a winner will be selected.